PTX 0.00% 4.2¢ prescient therapeutics limited

Live Investor briefing, page-76

  1. 7,803 Posts.
    lightbulb Created with Sketch. 3328
    Thanks, @Blue9288 re the upcoming webcast... well, the potential background for PTX-100 is starting to form a picture now. I had read some time ago that the prevalence of TCL cancer is much higher in Asia (PTCL and CTCL specifically too) than in the US. Following Bec's quote about OmniCAR in the article re Thermo Fisher launching the Cancer Consortium Centre in Singapore recently... I'm now starting to see the links and significance of where we are headed!

    https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(21)00035-3/fulltext

    Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia


    SYC stated in the recent webcast/s that the data coming from the PTX-100 trials has exceeded expectations!
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
0.000(0.00%)
Mkt cap ! $33.82M
Open High Low Value Volume
4.2¢ 4.2¢ 4.2¢ $4.464K 106.2K

Buyers (Bids)

No. Vol. Price($)
1 7343 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 403472 4
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.